Ardelyx's Tenapanor Data Challenge Phosphate Binders In Hyperphosphatemia

Although rate of diarrhea was higher for first-in-class tenapanor compared to phosphate binders in the first pivotal trial, drop-out rate is what counts and that was lower, say analysts, happy with the overall dataset.